Literature DB >> 18520188

Change of acoustic parameters before and after treatment in laryngopharyngeal reflux patients.

bBong Joon Jin1, Yong Seop Lee, Seung Won Jeong, Jin Hyeok Jeong, Seung Hwan Lee, Kyung Tae.   

Abstract

OBJECTIVES: To evaluate the usefulness of acoustic parameters as an indicator of laryngopharyngeal reflux (LPR) treatment efficacy. STUDY
DESIGN: A prospective case series analysis.
MATERIALS AND METHODS: From January to September 2005, we prospectively analyzed 40 patients who were diagnosed with laryngopharyngeal reflux by 24-hour ambulatory double-probe pH monitoring. Laryngopharyngeal reflux patients were treated medically and voice analysis was conducted three times: before treatment, 1 to 2 months after treatment, and 3 to 4 months after treatment. Jitter, shimmer, and harmonic-to-noise ratio (HNR) were analyzed as the acoustic parameters. Pre- and posttreatment reflux symptom index and reflux finding score were documented.
RESULTS: Jitter, shimmer, and HNR had improved significantly at 1 to 2 months after treatment and were maintained at 3 to 4 months after treatment. Jitter was significantly correlated with reflux symptom index.
CONCLUSION: Acoustic parameters can be used as indicators of treatment efficacy for laryngopharyngeal reflux disease.

Entities:  

Mesh:

Year:  2008        PMID: 18520188     DOI: 10.1097/MLG.0b013e3181651c3a

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Impact of age on laryngopharyngeal reflux disease presentation: a multi-center prospective study.

Authors:  Jérôme R Lechien; Camille Finck; Kathy Huet; Mohamad Khalife; Anne-Françoise Fourneau; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-17       Impact factor: 2.503

Review 2.  How to Approach Laryngopharyngeal Reflux: An Otolaryngology Perspective.

Authors:  Vaninder K Dhillon; Lee M Akst
Journal:  Curr Gastroenterol Rep       Date:  2016-08

3.  Gender differences in the presentation of dysphonia related to laryngopharyngeal reflux disease: a case-control study.

Authors:  Jérôme R Lechien; Kathy Huet; Mohamad Khalife; Anne-Françoise Fourneau; Camille Finck; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-26       Impact factor: 2.503

4.  Acoustic measurements are useful therapeutic indicators of patients with dysphonia-related to reflux.

Authors:  Alexandra Rodriguez; Stéphane Hans; Jerome R Lechien; Sven Saussez; Géraldine Nowak; Lise Crevier-Buchman; Marta P Circiu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-02-25       Impact factor: 2.503

Review 5.  Voice outcomes of laryngopharyngeal reflux treatment: a systematic review of 1483 patients.

Authors:  Jérôme R Lechien; Camille Finck; Pedro Costa de Araujo; Kathy Huet; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-23       Impact factor: 2.503

6.  Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial.

Authors:  Nicole Pizzorni; Federico Ambrogi; Angelo Eplite; Sibora Rama; Carlo Robotti; Jerome Lechien; Antonio Schindler
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-15       Impact factor: 3.236

7.  Impact of laryngopharyngeal reflux on subjective and objective voice assessments: a prospective study.

Authors:  Jérôme R Lechien; Kathy Huet; Mohamad Khalife; Anne-Françoise Fourneau; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  J Otolaryngol Head Neck Surg       Date:  2016-11-08

8.  Treatment of laryngopharyngeal reflux disease: A systematic review.

Authors:  Jerome R Lechien; Francois Mouawad; Maria R Barillari; Andrea Nacci; Seyyedeh Maryam Khoddami; Necati Enver; Sampath Kumar Raghunandhan; Christian Calvo-Henriquez; Young-Gyu Eun; Sven Saussez
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.